Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 9, 1979 - Issue 9
46
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Metabolic Studies of Ornidazole in the Rat, in the Dog and in Man

, , &
Pages 571-581 | Received 14 Nov 1978, Published online: 30 Sep 2009
 

Abstract

1. Ornidazole, labelled with 14C in the imidazole ring, administered orally to rats, dogs and men was largely excreted in the urine, predominantly as metabolites, with < 4% of the drug being excreted unchanged. Free and conjugated metabolites were found in the ratio of approx. 1:2.

2. The pattern of free ornidazole and metabolites was different in the three species: while ornidazole predominated in man, ornidazole and metabolite M1 in the dog, the most extensive metabolic pattern was found in the rat.

3. The following metabolites were identified: M1, 1-chloro-3-(2-hydroxymethyl-5-nitro-1-imidazolyl)-2-propanol; M2, 2-methyl-5-nitroimidazole; M3, N-(3-chloro-2-hydroxypropyl)acetamide; M4, 3-(2-methyl-5-nitro-1-imidazolyl)-1,2-propanediol; M5, acetamide.

4. The formation of metabolite M3 and M5 indicated cleavage of the imidazole ring between N-1/C-5 and C-2/C-3. Other ring scissions were not observed. Metabolites carryings a free amino group were not detected. On the basis of the structures identified, a scheme is suggested for the metabolism of ornidazole.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.